Cargando…
Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092640/ https://www.ncbi.nlm.nih.gov/pubmed/35571985 http://dx.doi.org/10.1093/noajnl/vdac051 |
| _version_ | 1784705176252186624 |
|---|---|
| author | Kaulen, Leon D Gumbinger, Christoph Hinz, Felix Kessler, Tobias Winkler, Frank Bendszus, Martin Sahm, Felix Wick, Wolfgang |
| author_facet | Kaulen, Leon D Gumbinger, Christoph Hinz, Felix Kessler, Tobias Winkler, Frank Bendszus, Martin Sahm, Felix Wick, Wolfgang |
| author_sort | Kaulen, Leon D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9092640 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90926402022-05-12 Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma Kaulen, Leon D Gumbinger, Christoph Hinz, Felix Kessler, Tobias Winkler, Frank Bendszus, Martin Sahm, Felix Wick, Wolfgang Neurooncol Adv Brief Communication Oxford University Press 2022-04-13 /pmc/articles/PMC9092640/ /pubmed/35571985 http://dx.doi.org/10.1093/noajnl/vdac051 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Brief Communication Kaulen, Leon D Gumbinger, Christoph Hinz, Felix Kessler, Tobias Winkler, Frank Bendszus, Martin Sahm, Felix Wick, Wolfgang Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title | Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title_full | Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title_fullStr | Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title_full_unstemmed | Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title_short | Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| title_sort | intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092640/ https://www.ncbi.nlm.nih.gov/pubmed/35571985 http://dx.doi.org/10.1093/noajnl/vdac051 |
| work_keys_str_mv | AT kaulenleond intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT gumbingerchristoph intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT hinzfelix intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT kesslertobias intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT winklerfrank intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT bendszusmartin intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT sahmfelix intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma AT wickwolfgang intraventricularimmunecheckpointinhibitionwithnivolumabinrelapsedprimarycentralnervoussystemlymphoma |